Molecular Diagnostics


Gastrointestinal Pathogen Panel

GI Panel tests for 22 of the most commonly associated pathogens related to gastroenteritis—all from one patient sample, one easy to use reagent, and results are available in about one hour.  Clinicians rarely receive accurate or timely answers with traditional stool testing methods and often have to make patient management decisions without a laboratory result. With the GPP Panel, timely and accurate results are provided that have been demonstrated to lead to more targeted therapy.

Pharmacogenomics

The Diagnostic Dilemma
Physicians have historically prescribed medications to patients without fully understanding how they will be processed in the patient’s body. Historically physicians used different variables such as height, weight and a number of other factors but these often proved to be ineffective for all patients. The issue is that patients often do not respond the same to a specific treatment regime and sometimes the treatment can actually have an adverse impact on the patient’s health.  

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field enables clinicians to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.  

The Solution
A2Z Diagnostics developed a unique and informative PGx algorithm that enables the right patient to receive the right therapy the first time.  Improving patient response to treatment and eliminating adverse impacts on prescribed medications

Respiratory Panel 2

Respiratory Panels are first-line tests to help clinicians quickly diagnose respiratory infections, which contribute to a significant healthcare burden and present with nearly indistinguishable symptoms.  Results have been shown to significantly reduce ICU days and duration of antibiotic use. Optimize patient management with clinically actionable results. RPP has been shown to reduce overall healthcare costs. Significant savings were demonstrated in an adult ICU population in both patients that tested positive for a respiratory pathogen as well as those that tested negative. RPP is much more sensitive than culture as well as turnaround time could be the same day or within 48-72 hours.

Urinary Tract Infection

The Diagnostic Dilemma
For years physicians have used a urine culture to detect urinary tract infections.  UTIs are some of the most common bacterial infections, affecting 150 million people each year worldwide. Traditional urinary cultures take a long time to get results typically 5-7 days and are not sensitive or accurate in detecting disease.  In fact, urinary cultures will miss up to 2/3 of the patients that have UTI and 50% of the patients with severe urinary symptoms underlining the need for more effective methods of diagnosis. Delayed turnaround time of results and inaccuracy of the diagnostic tool cost the healthcare system over 10 billion dollars a year and create unnecessary patient anxiety and stress

The Solution
A2Z Diagnostics and its world-class team have developed and launched a unique UTI molecular solution that provides a timely and accurate answer. Our panel identifies and guides appropriate treatment by identifying the genes associated with antibiotic resistance  

Wound care

The Diagnostic Dilemma
There has been a lot of improvements in wound dressings over the last few years.  Despite these advancements, the diagnostic options for ruling out infection have been limited to routine culture, which like many older technologies lacks sensitivity and specificity to detect disease, is time-consuming and typically does not recognize all pathogens.

It has been the norm for patients with chronic wounds to be placed on a regime of antibiotics.  This creates issues with the culture in that often times they will not grow while contributing to the global epidemic of antibiotic resistance.

The Solution
A2Z Diagnostics and its team have developed and launched an industry-leading molecular wound care solution that provides timely, accurate answers through our value-based technology platform. Our panel identifies and guides appropriate treatment by identifying the genes associated with antibiotic resistance.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google